🇺🇸 FDA
Pipeline program

A Study to Track How the Healthy Male Participants Handles the New Oral Drug RO7795081 for Weight Management and Diabetes

BP45932

Phase 1 other active

Quick answer

A Study to Track How the Healthy Male Participants Handles the New Oral Drug RO7795081 for Weight Management and Diabetes for Not Applicable is a Phase 1 program (other) at Roche Registration Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Roche Registration Limited
Indication
Not Applicable
Phase
Phase 1
Modality
other
Status
active

Clinical trials